Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cremonesi

Showing results (1-10 of 280) with videos related to

Pageof 28
Sort By:
Minerva Pediatrica|March 24, 1972
[Acid-base equilibrium in exchange-transfused newborn infants]C Bianchi, M Cremonesi, G Ferrari, et al.
Physics in Medicine and Biology|September 1, 2007
Influence of total-body mass on the scaling of S-factors for patient-specific, blood-based red-marrow dosimetryA C Traino, M Ferrari, M Cremonesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2006
Bisphosphonates and metastatic bone diseaseS Barni, M Mandalà, M Cazzaniga, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 18, 2006
Systemic and locoregional dosimetry in receptor radionuclide therapy with peptidesM Cremonesi, M Ferrari, L Bodei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
From the trastuzumab era to new target therapies: beyond revolutionS Barni, F Petrelli, M Cabiddu, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Receptor-mediated radionuclide therapy with 90Y-DOTA-D-Phe1-Tyr3-Octreotide: preliminary report in cancer patientsG Paganelli, S Zoboli, M Cremonesi, et al.
Oncology|February 5, 2003
Vinorelbine and carboplatin in inoperable non-small cell lung cancer: a monoinstitutional phase II studyM Cremonesi, M Mandalà, M Cazzaniga, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 10, 2011
Dosimetry in nuclear medicine therapy: radiobiology application and resultsL Strigari, M Benassi, C Chiesa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Acute dyspnea due to right phrenic palsy during infusional chemotherapyM Mandala, C Ciano, M Ghilardi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 6, 2019
Interim <sup>18</sup>F-FDG Positron Emission Tomography/Computed Tomography During Chemoradiotherapy in the Management of Cancer PatientsC Garibaldi, M Ferrari, C M Grana, et al.
Pageof 28

Showing results (1-10 of 280) with videos related to

Sort By:
Pageof 28
Minerva Pediatrica|March 24, 1972
[Acid-base equilibrium in exchange-transfused newborn infants]C Bianchi, M Cremonesi, G Ferrari, et al.
Physics in Medicine and Biology|September 1, 2007
Influence of total-body mass on the scaling of S-factors for patient-specific, blood-based red-marrow dosimetryA C Traino, M Ferrari, M Cremonesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2006
Bisphosphonates and metastatic bone diseaseS Barni, M Mandalà, M Cazzaniga, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 18, 2006
Systemic and locoregional dosimetry in receptor radionuclide therapy with peptidesM Cremonesi, M Ferrari, L Bodei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
From the trastuzumab era to new target therapies: beyond revolutionS Barni, F Petrelli, M Cabiddu, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Receptor-mediated radionuclide therapy with 90Y-DOTA-D-Phe1-Tyr3-Octreotide: preliminary report in cancer patientsG Paganelli, S Zoboli, M Cremonesi, et al.
Oncology|February 5, 2003
Vinorelbine and carboplatin in inoperable non-small cell lung cancer: a monoinstitutional phase II studyM Cremonesi, M Mandalà, M Cazzaniga, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 10, 2011
Dosimetry in nuclear medicine therapy: radiobiology application and resultsL Strigari, M Benassi, C Chiesa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Acute dyspnea due to right phrenic palsy during infusional chemotherapyM Mandala, C Ciano, M Ghilardi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 6, 2019
Interim <sup>18</sup>F-FDG Positron Emission Tomography/Computed Tomography During Chemoradiotherapy in the Management of Cancer PatientsC Garibaldi, M Ferrari, C M Grana, et al.
Pageof 28